Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Xcelience to Develop and Manufacture DEA Schedule I Drug Products | Contract Pharma

What are you searching for?

Sign in
Breaking News

Xcelience to Develop and Manufacture DEA Schedule I Drug Products

Clinicians continue to find potential therapeutic indications for Schedule I drug substances

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Xcelience, a CDMO located in Tampa, FL, has received approval from the Federal Drug Enforcement Agency (DEA) to develop and manufacture Schedule I controlled substances in their facilities. Schedule I substances are “considered the most dangerous class of drugs,” according to the DEA website. Xcelience has a long history of working with DEA controlled substances and this license extension completes their approval to now handle both analytical and manufacturing of the full spectrum of DEA Scheduled products. Clinicians continue to find potential therapeutic indications for Schedule I drug substances.

“Regulatory capability is a critical attribute for CDMOs,” said Alex McClung, vice president, quality at Xcelience. “This Schedule I-V license underscores our capability and extends our suite of services to a whole new class of therapeutic compounds.”

Being able to work on Schedule I controlled substances will enhance Xcelience’s research capabilities and expand the types of research programs the company can support. This news comes in addition to their announcement for expansion. Xcelience is expanding its pharmaceutical development services and manufacturing capacity by adding a new facility in the Tampa area to include more pharmaceutical development labs, manufacturing, quality assurance and packaging services.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics